Tae-Heum Jeong
Amministratore Delegato presso SV Investment Corp/US/
Profilo
Tae-Heum Jeong is the founder and currently holds the position of Executive Advisor at KSV Global, which was founded in 2018.
He is also currently the Chairman at Nurron Pharmaceuticals, Inc. since 2020 and the Managing Partner at SV Investment Corp since 2018.
Mr. Jeong previously served as the CFO at Rexahn Pharmaceuticals, Inc. from 2003 to 2017 and as a Senior Investment Manager at Hyundai Venture Investment Corp.
from 1997 to 2002.
He was also a Board Member at Shuttle Pharmaceuticals Holdings, Inc. from 2018 to 2020 and at NeuroBo Pharmaceuticals, Inc. from 2019 to 2021.
Additionally, Mr. Jeong was the Chief Financial Officer at Clene, Inc. from 2020 to 2022.
He completed his graduate studies at Pohang University of Science & Technology, The Johns Hopkins University, and the University of Maryland.
Posizioni attive di Tae-Heum Jeong
| Società | Posizione | Inizio |
|---|---|---|
| SV Investment Corp/US/ | Amministratore Delegato | 01/01/2018 |
KSV Global
 KSV Global Investment ManagersFinance KSV Global Innovations LP provides investment services. The company was founded by Dan Gay, Jon Gay, Ted Jeong, and Spencer Nam in 2018 and is headquartered in Boston, MA. | Consulente / Consigliere | 01/01/2018 |
Precedenti posizioni note di Tae-Heum Jeong
| Società | Posizione | Fine |
|---|---|---|
| CLENE INC. | Direttore Finanziario/CFO | 01/01/2022 |
| NEUROBO PHARMACEUTICALS, INC. | Direttore/Membro del Consiglio | 01/01/2021 |
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Direttore/Membro del Consiglio | 01/01/2020 |
| REXAHN PHARMACEUTICALS, INC. | Direttore Finanziario/CFO | 01/01/2017 |
Hyundai Venture Investment Corp.
 Hyundai Venture Investment Corp. Investment ManagersFinance Hyundai Venture Investment Corp. (HVIC) is the venture capital arm of Hyundai Finance Corp., founded in 1997. The firm is headquartered in Seoul, South Korea. | Investitore di Private Equity | 01/01/2002 |
Formazione di Tae-Heum Jeong
| Pohang University of Science & Technology | Graduate Degree |
| The Johns Hopkins University | Graduate Degree |
| University of Maryland | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 3 |
|---|---|
| SHUTTLE PHARMACEUTICALS HOLDINGS, INC. | Health Technology |
| NEUROBO PHARMACEUTICALS, INC. | Health Technology |
| CLENE INC. | Health Technology |
| Aziende private | 4 |
|---|---|
Rexahn Pharmaceuticals, Inc.
 Rexahn Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Rexahn Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the research and development of oncology therapeutics. Its drug candidates include the following: RX-31171 for pancreatic, bladder, colon, and lung cancer; and RX-5902 for metastatic triple negative breast cancer. The company was founded by Chang Ho Ahn on March 19, 2001 and is headquartered in Rockville, MD. | Health Technology |
Hyundai Venture Investment Corp.
Hyundai Venture Investment Corp. Investment ManagersFinance Hyundai Venture Investment Corp. (HVIC) is the venture capital arm of Hyundai Finance Corp., founded in 1997. The firm is headquartered in Seoul, South Korea. | Finance |
KSV Global
KSV Global Investment ManagersFinance KSV Global Innovations LP provides investment services. The company was founded by Dan Gay, Jon Gay, Ted Jeong, and Spencer Nam in 2018 and is headquartered in Boston, MA. | Finance |
| SV Investment Corp/US/ | Finance |
- Borsa valori
- Insiders
- Tae-Heum Jeong
